Clinical Laserthermia Systems
18 SEK -5,96%1 investor følger denne virksomhed
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Omsætning
8,27 mio.
EBIT %
-797,22 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
CLS B
Daglig lav / høj pris
17,9 / 21,93
SEK
Markedsværdi
141,33 mio. SEK
Aktieomsætning
160,54 t SEK
Volumen
8,3 t
Finanskalender
Delårsrapport
17.05.2024
Generalforsamling
28.06.2024
Delårsrapport
23.08.2024
Delårsrapport
15.11.2024
Årsrapport
21.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Avanza Pension | 7,1 % | 6,8 % |
Handelsbanken Liv Försäkringsaktiebolag | 4,7 % | 4,6 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
CLS: Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB
BioStock: CLS makes progress in prostate cancer in Europe and the US
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools